PM
Prosight Management Portfolio holdings
AUM
$410M
This Quarter Return
-1.43%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$203M
AUM Growth
+$203M
(+0.6%)
Cap. Flow
-$7.15M
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
50.42%
Holding
59
New
11
Increased
16
Reduced
17
Closed
14
Top Buys
| 1 |
Aurinia Pharmaceuticals
AUPH
|
$7.41M |
| 2 |
Baxter International
BAX
|
$6.39M |
| 3 |
Cue Biopharma
CUE
|
$6.01M |
| 4 |
Prothena Corp
PRTA
|
$5.45M |
| 5 |
MTCR
Metacrine, Inc. Common Stock
MTCR
|
$5.3M |
Top Sells
| 1 |
Kura Oncology
KURA
|
$17.7M |
| 2 |
Arrowhead Research
ARWR
|
$4.93M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$4.8M |
| 4 |
Aldeyra Therapeutics
ALDX
|
$3.91M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$3.11M |
Sector Composition
| 1 | Healthcare | 92.16% |
| 2 | Technology | 4.47% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Organogenesis Holdings
ORGO
$629M
| $2.6M | 1.24% |
676,553
+140,937
| +26% | +$541K |
|
|
TVRD
27
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $2.22M | 1.06% |
174,644
+87,679
| +101% | +$1.12M |
|
28
Amneal Pharmaceuticals
AMRX
$3B
| $1.99M | 0.95% |
+512,659
| New | +$1.99M |
|
|
ONEM
29
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $1.87M | 0.89% |
+65,778
| New | +$1.87M |
|
30
Kezar Life Sciences
KZR
$28.5M
| $1.77M | 0.84% |
+365,981
| New | +$1.77M |
|
31
Dianthus Therapeutics
DNTH
$781M
| $1.66M | 0.79% |
244,252
+75,674
| +45% | +$515K |
|
32
QuidelOrtho
QDEL
$1.87B
| $1.65M | 0.78% |
+7,500
| New | +$1.65M |
|
33
Establishment Labs
ESTA
$1.11B
| $1.59M | 0.76% |
86,042
-41,131
| -32% | -$762K |
|
34
Gyre Therapeutics
GYRE
$734M
| $1.3M | 0.62% |
301,678
+53,628
| +22% | +$231K |
|
35
BioXcel Therapeutics
BTAI
$52.7M
| $1.29M | 0.61% |
+29,800
| New | +$1.29M |
|
36
ADMA Biologics
ADMA
$4.03B
| $1.28M | 0.61% |
535,324
-763,976
| -59% | -$1.83M |
|
|
KRTX
37
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.22M | 0.58% |
+15,826
| New | +$1.22M |
|
38
Immatics
IMTX
$662M
| $1.2M | 0.57% |
+113,460
| New | +$1.2M |
|
39
Neurogene
NGNE
$284M
| $797K | 0.38% |
+66,376
| New | +$797K |
|
|
EVFM
40
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $590K | 0.28% |
250,000
-162,788
| -39% | -$384K |
|
|
APEN
41
DELISTED
Apollo Endosurgery, Inc.
APEN
| $469K | 0.22% |
277,590
-102,355
| -27% | -$173K |
|
42
OrthoPediatrics
KIDS
$524M
| $386K | 0.18% |
+8,399
| New | +$386K |
|
|
MITO
43
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
| $346K | 0.16% |
256,044
-35,100
| -12% | -$47.4K |
|
|
BEAT
44
DELISTED
BioTelemetry, Inc.
BEAT
| $274K | 0.13% |
6,000
-18,733
| -76% | -$855K |
|
45
AMN Healthcare
AMN
$760M
| – | – |
-26,851
| Closed | -$1.22M |
|
|
46
Arrowhead Research
ARWR
$3.84B
| – | – |
-114,100
| Closed | -$4.93M |
|
47
Evolus
EOLS
$477M
| – | – |
-281,541
| Closed | -$1.49M |
|
48
Immunovant
IMVT
$2.91B
| – | – |
-95,500
| Closed | -$2.33M |
|
|
MODV
49
DELISTED
ModivCare
MODV
| – | – |
-14,923
| Closed | -$1.18M |
|
50
NeoGenomics
NEO
$1.06B
| – | – |
-38,819
| Closed | -$1.2M |
|